CSL – Buy

CSL has lobbed a US$11.7bn all cash public tender offer for Switzerland based specialty drug company Vifor Pharma.

The acquisition is being funded via a combination of a private placement, SPP and cash/debt, with commencement around 18 Jan-22.

You’re not a member!  Trial today

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.